<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><link>http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.html</link><atom:link rel="self" href="http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.html"/><title>Life Technologies Press Releases</title><description/><pubDate>Thu, 25 Feb 2010 15:58:29 -0600</pubDate><generator>http://www.day.com/communique</generator>

	
		
			<item>
				<title>Life Technologies to Present at the UBS Global Life Sciences 
 Conference</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-to-preset-at-the-ubs-global-life-scieces--cofer.html</link>
				<description><![CDATA[
					 CARLSBAD, Calif., Sep 03, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) today announced it will 
      present at the UBS Global Life Sciences Conference on Wednesday, 
      September 22 at 8:30 a.m. EDT. Greg Lucier, Life Technologies' Chairman 
      and Chief Executive Officer, will present on behalf of the company. The 
      company will webcast the presentation, which will be available on the 
      Life Technologies' investor relations website for two weeks fo&#133;
				]]></description>
				<pubDate>Fri, 03 Sep 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-to-preset-at-the-ubs-global-life-scieces--cofer.html</guid>
			</item>
		
			<item>
				<title>Life Technologies and SG Biofuels Complete Sequence of Jatropha Genome</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-ad-sg-biofuels-complete-sequece-of-jatropha-geo.html</link>
				<description><![CDATA[
					  Sequence Combined with Largest Germplasm Library Accelerates Development of Promising Energy Crop   
 CARLSBAD, Calif., Aug 24, 2010 /PRNewswire via COMTEX/ -- 
  Life Technologies Corporation  (Nasdaq: LIFE), a provider of innovative life science solutions and  SG Biofuels, Inc. , a bioenergy crop company, today announced they have completed sequencing the  Jatropha curcas  genome to 100x coverage, using the  SOLiD(TM) 4.0 System  by Life Technologies. The sequence significantly accelera&#133;
				]]></description>
				<pubDate>Tue, 24 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-ad-sg-biofuels-complete-sequece-of-jatropha-geo.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Launches 3500 Dx Series Genetic Analyzer in Asia 
 Pacific</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-lauches-3500-dx-series-geetic-aalyzer-i-asia--p.html</link>
				<description><![CDATA[
					  Product to Be Introduced in Australia, India, New Zealand, Singapore and Taiwan for In Vitro Diagnostic Use  
 CARLSBAD, Calif., Aug 23, 2010 (BUSINESS WIRE) -- 
 Life  Technologies Corporation (NASDAQ: LIFE) today announced that its  Applied Biosystems(TM) 3500 Dx Series Genetic Analyzers , the first CE IVD-marked capillary electrophoresis system for nucleic acid analysis, are now available for sale in Australia, India, New Zealand, Singapore, and Taiwan.  
  
 The 3500 Dx Series Genetic&#133;
				]]></description>
				<pubDate>Mon, 23 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-lauches-3500-dx-series-geetic-aalyzer-i-asia--p.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Announces Agreement to Acquire Ion Torrent</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-aouces-agreemet-to-acquire-io-torret.html</link>
				<description><![CDATA[
					  Ion Torrent's First to Market PostLight(TM) Sequencing Technology to Expand Life Technologies' Leadership Position in Sequencing Complements Existing Sequencing Solutions Portfolio  
 CARLSBAD, Calif. &amp; GUILFORD, Conn., Aug 17, 2010 (BUSINESS WIRE) -- 
 Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced a definitive agreement to acquire Ion Torrent for $375 million in cash and stock.  
 The sellers are entitled to additional &#133;
				]]></description>
				<pubDate>Tue, 17 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-aouces-agreemet-to-acquire-io-torret.html</guid>
			</item>
		
			<item>
				<title>Life Technologies and UCSD Establish a High-Throughput Sequencing 
 Genomics Research Program Exclusively Using the SOLiD System</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-ad-ucsd-establish-a-high-throughput-sequecig--g.html</link>
				<description><![CDATA[
					    National Institutes of Health Funding Enables Use of SOLiD 4 
      Technology for Cancer Biomarker Research     
 CARLSBAD &amp; LA JOLLA, Calif., Aug 05, 2010 (BUSINESS WIRE) -- Life  Technologies Corporation (NASDAQ: LIFE) and the  University 
      of California at San Diego Moores Cancer Center  today announced a 
      partnership to use  SOLiD(TM) 
      4  genomic analysis technology in a research program to study chronic 
      lymphocytic leukemia (CLL), a cancer of the white &#133;
				]]></description>
				<pubDate>Thu, 05 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-ad-ucsd-establish-a-high-throughput-sequecig--g.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Introduces New Forensic DNA Extraction System</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-itroduces-ew-foresic-da-extractio-system.html</link>
				<description><![CDATA[
					    System Designed and Validated for Complete Applied Biosystems Human 
      Identification Workflow     
 CARLSBAD, Calif., Aug 04, 2010 (BUSINESS WIRE) -- Life  Technologies Corporation (NASDAQ:LIFE) today announced the 
      commercial availability of the  Applied 
      Biosystems AutoMate  Express (TM) Forensic DNA Extraction System , 
      which is designed to streamline sample preparation and improve 
      downstream DNA profile quality. The system, designed and validated as 
  &#133;
				]]></description>
				<pubDate>Wed, 04 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-itroduces-ew-foresic-da-extractio-system.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Introduces Test for Rapid Detection of E. coli</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-itroduces-test-for-rapid-detectio-of-e.html</link>
				<description><![CDATA[
					   MicroSEQ E. coli O157:H7 Detection Assay Also Receives Industry Validation from AOAC Research Institute  
 CARLSBAD, Calif., Aug 02, 2010 (BUSINESS WIRE) --
 Life Technologies (NASDAQ:LIFE), a provider of innovative life science solutions, announced at the International Association of Food Protection annual meeting the launch of the MicroSEQ(R)  E. coli  O157:H7 assay, designed to detect the deadly strain of  Escherichia coli  ( E. coli ), using the company's industry-leading real-time P&#133;
				]]></description>
				<pubDate>Mon, 02 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-itroduces-test-for-rapid-detectio-of-e.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Provides Notice of Contingent Interest Payment to 
 2% Convertible Senior Note Holders</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-provides-otice-of-cotiget-iterest-paymet-to--2-.html</link>
				<description><![CDATA[
					 CARLSBAD, Calif., Aug 02, 2010 (BUSINESS WIRE) -- As required under the indentures covering Invitrogen Corporation 2% 
      Convertible Senior Notes due 2023 (cusips 46185RAF7 and 46185RAJ9) Life 
      Technologies Corporation (NASDAQ: LIFE) (as successor to Invitrogen 
      Corporation) is providing public notice to the holders of these bonds 
      that they have the right to receive contingent interest for the 
      quarterly interest period beginning August 1, 2010. As the notes ha&#133;
				]]></description>
				<pubDate>Mon, 02 Aug 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-provides-otice-of-cotiget-iterest-paymet-to--2-.html</guid>
			</item>
		
			<item>
				<title>Life Technologies Announces Second Quarter 2010 Results; $350 Million  Share Repurchase Authorization</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-aouces-secod-quarter-2010-results.html</link>
				<description><![CDATA[
					    Second quarter GAAP revenue of $904 million and non-GAAP revenue of $906 million     Second quarter GAAP earnings per share of $0.58 and non-GAAP earnings per share of $0.91     Free cash flow of $203 million in the second quarter       
 CARLSBAD, Calif., Jul 29, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over &#133;
				]]></description>
				<pubDate>Thu, 29 Jul 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/life-techologies-aouces-secod-quarter-2010-results.html</guid>
			</item>
		
			<item>
				<title>Asuragen and Life Technologies Launch CE-Marked BCR/ABL1 Quant(TM) 
 Leukemia Test in Europe</title>
				<link>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/asurage-ad-life-techologies-lauch-ce-marked-bcr.html</link>
				<description><![CDATA[
					 AUSTIN, Texas &amp; CARLSBAD, Calif., Jul 13, 2010 (BUSINESS WIRE) --  Asuragen, 
      Inc.  and  Life 
      Technologies Corporation  (NASDAQ: LIFE) announced today that they 
      have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 
      Quant(TM) Test, Asuragen's clinically validated and cGMP manufactured test 
      intended to aid clinicians in the monitoring and treatment of 
      individuals afflicted with chronic myeloid leukemia (CML). Asuragen 
      man&#133;
				]]></description>
				<pubDate>Tue, 13 Jul 2010 00:00:00 -0500</pubDate>
				<guid>http://www.lifetechnologies.com/content/lifetech/en/home/news-gallery/press-releases/2010/asurage-ad-life-techologies-lauch-ce-marked-bcr.html</guid>
			</item>
		
	
	
	

</channel>
</rss>
